HPMM (Hemp Naturals) Debt-to-EBITDA : -0.02 (As of Nov. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hemp Naturals Debt-to-EBITDA?

Hemp Naturals HPMM -95.00% Debt-to-EBITDA is -0.02 as of Nov. 2018.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Hemp Naturals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2018 was $0.07 Mil. Hemp Naturals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Nov. 2018 was $0.00 Mil. Hemp Naturals's annualized EBITDA for the quarter that ended in Nov. 2018 was $-4.41 Mil. Hemp Naturals's annualized Debt-to-EBITDA for the quarter that ended in Nov. 2018 was -0.02.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Hemp Naturals's Debt-to-EBITDA or its related term are showing as below:

HPMM's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.62
* Ranked among companies with meaningful Debt-to-EBITDA only.

Hemp Naturals  (OTCPK:HPMM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Hemp Naturals Debt-to-EBITDA Related Terms


Hemp Naturals Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Hemp Naturals's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemp Naturals Debt-to-EBITDA Chart

Hemp Naturals Annual Data
Trend Nov15 Nov16 Nov17 Nov18
Debt-to-EBITDA
N/A 0.00 0.00 -0.01

Hemp Naturals Quarterly Data
Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.01 -0.02

HPMM vs RDGL, NBGV, BKIT: Debt-to-EBITDA Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hemp Naturals's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hemp Naturals Debt-to-EBITDA vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hemp Naturals's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hemp Naturals's Debt-to-EBITDA falls into.



Hemp Naturals Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Hemp Naturals's Debt-to-EBITDA for the fiscal year that ended in Nov. 2018 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.073 + 0) / -6.028
=-0.01

Hemp Naturals's annualized Debt-to-EBITDA for the quarter that ended in Nov. 2018 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.073 + 0) / -4.408
=-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Nov. 2018) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -0.02 mean?
Hemp Naturals (HPMM) has a Debt-to-EBITDA of -0.02 as of Nov. 2018. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Hemp Naturals.
Is Hemp Naturals' Debt-to-EBITDA too high?
Hemp Naturals' current Debt-to-EBITDA is -0.02.
How does Hemp Naturals' Debt-to-EBITDA compare to RDGL and NBGV?
Hemp Naturals' Debt-to-EBITDA of -0.02 can be compared against companies in the Drug Manufacturers industry. The industry median Debt-to-EBITDA is 1.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.62, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Hemp Naturals. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemp Naturals's current Debt-to-EBITDA is -0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemp Naturals stock overvalued right now?
Hemp Naturals (HPMM) has a current Debt-to-EBITDA of -0.02. The current Debt-to-EBITDA is -0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Hemp Naturals (HPMM), the current Debt-to-EBITDA is -0.02 as of Nov. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemp Naturals Business Description

Address 7441 Route 9, Plattsburgh, NY, USA, 12901
Hemp Naturals Inc is a developmental stage company that plans to research, develop, acquire, and sell products made of industrial hemp. Its product offerings include a wide range of nutritional hemp health supplements, hemp drinks and foods, and beauty supply products.